19 reports

  • Epistem Holdings Plc Pipeline Products by Indication
  • Epistem Holdings Plc Pipeline Products Summary by Development Stage
  • Tuberculosis
  • India
  • World
  • Epistem Holdings Plc
  • GlobalData's company
  • Profiles of Tuberculosis Drugs Producers

APIs such as alleviate fever & analgesia, semi-synthetic antibiotics, cardiograph, anti-tuberculosis and gastrointestinal spasms are mainly produced in SIPC.

  • Tuberculosis
  • China
  • Demand
  • Market Size
  • Shandong Lukang Pharmaceutical Co., Ltd

It also offers a variety of assays for breast, colon, pancreatic, testicular, gastrointestinal, liver, ovarian, and prostate cancer; cardiac; fertility/ pregnancy; infectious disease; metabolic (liver and kidney function); proteins; and thyroid.

  • Tuberculosis
  • World
  • Market Size
  • Alere Inc.
  • Roche Group
  • Profiles of Tuberculosis Drugs Producers

APIs such as alleviate fever & analgesia, semi-synthetic antibiotics, cardiograph, anti-tuberculosis and gastrointestinal spasms are mainly produced in SIPC.

  • Tuberculosis
  • China
  • Guangzhou Baiyunshan Pharmaceutical Co., Ltd.
  • Shandong Lukang Pharmaceutical Co., Ltd
  • Shenyang Shuangding Pharmaceutical Co., Ltd.

The several types of TB based on the site of infection are pulmonary TB (lungs), skeletal TB (bone and joints), pleural TB, lymph node TB, gastrointestinal TB, and TB meningitis.

  • Pathology
  • Tuberculosis
  • World
  • Market Size

Food and Drug Administration (FDA) to market the FilmArray Torch for use with the FilmArray Blood Culture Identification (BCID) Panel, Gastrointestinal (GI) Panel, and Meningitis/ Encephalitis (ME) Panel.

  • Diagnostics
  • Hospital
  • Tuberculosis
  • Market Size
  • Alere Inc.
  • Global Markets Direct Report Coverage

Report covers products from therapy areas Gastrointestinal, Infectious Disease and Immunology which include indications Inflammatory Bowel Disease, Tuberculosis, Plaque Psoriasis (Psoriasis Vulgaris), Pulmonary Tuberculosis and Ulcerative Colitis.

  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • TENNOR ACQUIRES PATENTS FROM TB ALLIANCE

Although they were found not to be suitable in treating TB, they may hold value in treating infectious diseases of the gastrointestinal (GI) tract.

  • Pathology
  • Pharmaceutical
  • Tuberculosis
  • World
  • TB Drug Development, Inc.

Gastrointestinal ## ## Infectious Disease ## ## Immunology ## ## Source: Global Markets Direct Therapy Area Company Universities/ Institutes H+ Transporting Two Sector ATPase (F##F## ATP Synthase or ATP Synthase or Mitochondrial ATPase or Bacterial Ca##+/ Mg##+ ATPase or EC ##. ##. ##. ##) - Produc

  • Antibiotic Resistance
  • Tuberculosis
  • World
  • Product Initiative
  • Lycera Corp.
  • TUBERCULOSIS - PIPELINE BY OTSUKA HOLDINGS CO LTD, H1 2017
  • TUBERCULOSIS - PIPELINE BY EISAI CO LTD, H1 2017

The company' s franchise areas in research include neurology, oncology, vascular and immunological reaction, gastrointestinal disorders, and musculoskeletal diseases.

  • DNA
  • Tuberculosis
  • United States
  • World
  • Product Initiative
  • Clinical Trial profile. 109 Trial Title
  • Clinical Trial Profile Snapshots

Gastrointestinal Tract Disorders A Clinical Study of Anti-TB Drugs in Patients with Gastrointestinal Tract Disorders GDCT## GDC##, Infectious Disease Pulmonary Tuberculosis Completed Phase II Interventional ethambutol; isoniazid; pyrazinamide; rifamycin CR National Insti

  • Anti-Infective
  • Therapy
  • Tuberculosis
  • World
  • Product Initiative
  • TUBERCULOSIS - PIPELINE BY AKTHELIA PHARMACEUTICALS LIMITED, H2 2016
  • TUBERCULOSIS - PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • Tuberculosis
  • World
  • Company
  • Product Initiative
  • TB Drug Development, Inc.
  • Oct 06, 2017: FDA awards 15 grants for clinical trials to stimulate product development for...

The company' s products focus at treating central nervous system, ear nose throat, musculoskeletal, metabolic and hematological disorders; infectious diseases; respiratory diseases; cardiovascular diseases; dermatology diseases; gastrointestinal diseases; cancer and other diseases.

  • Cancer
  • Pharmaceutical
  • Tuberculosis
  • United States
  • GlobalData's company
  • Clinical Trial Profile Snapshots

Gastrointestinal Tract Disorders A Clinical Study of Anti-TB Drugs in Patients with Gastrointestinal Tract Disorders GDCT## GDC##, Infectious Disease Pulmonary Tuberculosis Completed Phase II Interventional ethambutol; isoniazid; pyrazinamide; rifamycin CR National Insti

  • Clinical Trial
  • Infectious Disease
  • Tuberculosis
  • World
  • TB Drug Development, Inc.

GASTROINTESTINAL CELIAC DISEASE GASTRITIS DATE PARTIES INFLAMMATORY BOWEL DISEASE STAGE VALUE US$M SUBJECT CONTRACT ##. ## GRANT AWARD FOR $##. ## MILLION FOR MAY 2017 NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES, PROTAGONIST THERAPEUTICS DEVELOPING BIOMARKERS THAT DEFINE IL

  • Biomarker
  • Healthcare
  • Tuberculosis
  • United States
  • Company Operations

It is a gastrointestinal agent.

  • Cancer
  • Targeted Therapy
  • Therapy
  • Tuberculosis
  • Novartis AG

Cholecystokinin (CCK) is involved in gastrointestinal motor response to meals.

  • Infectious Disease
  • Therapy
  • Tuberculosis
  • United States
  • Sanofi S.A.

Budesonide (Entocort, Entocort EC) is a gastrointestinal agent.

  • Cancer
  • Therapy
  • Tuberculosis
  • United States
  • AstraZeneca PLC

The company' s research resources are focused on asthma, chronic obstructive pulmonary disease (COPD), gastrointestinal disorders, psoriasis and other dermatological conditions.

  • Healthcare
  • Hospital
  • Pharmaceutical
  • Tuberculosis
  • BioFocus DPI Limited